The population’s immunity to SARS-CoV-2, achieved either through infection or vaccination, is crucial to overcome the COVID-19 pandemic. A team of researchers led by the University of Zurich (UZH) has now discovered another component that contributes to SARS-CoV-2 immunity – previous antibody responses to other, harmless coronaviruses.
Exposure to harmless coronaviruses boosts SARS-CoV-2 immunity
November 23, 2021
Related blog posts
New drug shows promise for fighting both COVID-19 and cancer
November 15, 2022